Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-tailored vs Standard Factor VIII Dosing in Severe Haemophilia A
NCT02697370Phase 4Completed
- Sponsor
- Hampshire Hospitals NHS Foundation Trust
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Factor VIII in hemophilia A, sponsored by Hampshire Hospitals NHS Foundation Trust. Primary endpoint: Number of clinically significant bleeds at 18 months. Started Apr 2013; status: completed.
02
Drugs
Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02697370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697370.